{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:33:10Z","timestamp":1787239990608,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    NANS-CDG is a recently described congenital disorder of glycosylation caused by biallelic genetic variants in\n                    <jats:italic>NANS<\/jats:italic>\n                    , encoding an essential enzyme in\n                    <jats:italic>de novo<\/jats:italic>\n                    sialic acid synthesis. Sialic acid at the end of glycoconjugates plays a key role in biological processes such as brain and skeletal development. Here, we present an observational cohort study to delineate the genetic, biochemical, and clinical phenotype and assess possible correlations.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Medical and laboratory records were reviewed with retrospective extraction and analysis of genetic, biochemical, and clinical data (2016\u20132020).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Nine NANS-CDG patients (nine families, six countries) referred to the Radboudumc CDG Center of Expertise were included. Phenotyping confirmed the hallmark features including intellectual developmental disorder (IDD) (\n                    <jats:italic>n<\/jats:italic>\n                    = 9\/9; 100%), facial dysmorphisms (\n                    <jats:italic>n<\/jats:italic>\n                    = 9\/9; 100%), neurologic impairment (\n                    <jats:italic>n<\/jats:italic>\n                    = 9\/9; 100%), short stature (\n                    <jats:italic>n<\/jats:italic>\n                    = 8\/9; 89%), skeletal dysplasia (\n                    <jats:italic>n<\/jats:italic>\n                    = 8\/9; 89%), and short limbs (\n                    <jats:italic>n<\/jats:italic>\n                    = 8\/9; 89%). Newly identified features include ophthalmological abnormalities (\n                    <jats:italic>n<\/jats:italic>\n                    = 6\/9; 67%), an abnormal septum pellucidum (\n                    <jats:italic>n<\/jats:italic>\n                    = 6\/9; 67%), (progressive) cerebral atrophy and ventricular dilatation (\n                    <jats:italic>n<\/jats:italic>\n                    = 5\/9; 56%), gastrointestinal dysfunction (\n                    <jats:italic>n<\/jats:italic>\n                    = 5\/9; 56%), thrombocytopenia (\n                    <jats:italic>n<\/jats:italic>\n                    = 5\/9; 56%), and hypo\u2013low-density lipoprotein cholesterol (\n                    <jats:italic>n<\/jats:italic>\n                    = 4\/9; 44%). Biochemically, elevated urinary excretion of\n                    <jats:italic>N<\/jats:italic>\n                    -acetylmannosamine (ManNAc) is pathognomonic, the concentrations of which show a significant correlation with clinical severity. Genotypically, eight novel\n                    <jats:italic>NANS<\/jats:italic>\n                    variants were identified. Three severely affected patients harbored identical compound heterozygous pathogenic variants, one of whom was initiated on experimental prenatal and postnatal treatment with oral sialic acid. This patient showed markedly better psychomotor development than the other two genotypically identical males.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    ManNAc screening should be considered in all patients with IDD, short stature with short limbs, facial dysmorphisms, neurologic impairment, and an abnormal septum pellucidum +\/\u2013 congenital and neurodegenerative lesions on brain imaging, to establish a precise diagnosis and contribute to prognostication. Personalized management includes accurate genetic counseling and access to proper supports and tailored care for gastrointestinal symptoms, thrombocytopenia, and epilepsy, as well as rehabilitation services for cognitive and physical impairments. Motivated by the short-term positive effects of experimental treatment with oral sialic, we have initiated this intervention with protocolized follow-up of neurologic, systemic, and growth outcomes in four patients. Research is ongoing to unravel pathophysiology and identify novel therapeutic targets.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.668640","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T02:36:41Z","timestamp":1623033401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical Spectrum"],"prefix":"10.3389","volume":"12","author":[{"given":"Bibiche","family":"den Hollander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rasing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel A.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemijn M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machteld M.","family":"Oud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion M.","family":"Brands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo F. H.","family":"Engelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Essen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine A.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Haaxma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynjar O.","family":"Jensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. J.","family":"Kluijtmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaske D.","family":"Lichtenbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsebet","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gera","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Salvarinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen E. H.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3lafur","family":"Thorarensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Ulmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien L. M.","family":"Coene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8l A.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Lefeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara D. M. van","family":"Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.11613\/BM.2012.019","article-title":"Insights into complexity of congenital disorders of glycosylation","volume":"22","author":"Goreta","year":"2012","journal-title":"Biochem Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.ejcn.1601704","article-title":"The role and potential of sialic acid in human nutrition","volume":"57","author":"Wang","year":"2003","journal-title":"Eur J Clin Nutr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.nutr.28.061807.155515","article-title":"Sialic acid is an essential nutrient for brain development and cognition","volume":"29","author":"Wang","year":"2009","journal-title":"Annu Rev Nutr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/10408398.2015.1040113","article-title":"The nutritional role of free sialic acid, a human milk monosaccharide, and its application as a functional food ingredient","volume":"57","author":"R\u00f6hrig","year":"2017","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ng.3578","article-title":"NANS-mediated synthesis of sialic acid is required for brain and skeletal development","volume":"48","author":"van Karnebeek","year":"2016","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.07.010","article-title":"Treatment of neurogenetic developmental conditions: from 2016 into the future","volume":"65","author":"van Karnebeek","year":"2016","journal-title":"Pediatr Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.21037\/tp.2020.02.02","article-title":"A clinical primer on intellectual disability","volume":"9","author":"Patel","year":"2020","journal-title":"Transl Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41436-020-0767-8","article-title":"Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG","volume":"22","author":"Witters","year":"2020","journal-title":"Genet Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3233\/JND-159900","article-title":"Aceneuramic acid extended release administration maintains upper limb muscle strength in a 48-week study of subjects with GNE myopathy: results from a phase 2, randomized, controlled study","volume":"3","author":"Argov","year":"2016","journal-title":"J Neuromuscul Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000006932","article-title":"A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy","volume":"92","author":"Lochm\u00fcller","year":"2019","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10545-011-9325-5","article-title":"Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression","volume":"34","author":"Achouitar","year":"2011","journal-title":"J Inherit Metab Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","article-title":"Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients","volume":"41","author":"Coene","year":"2018","journal-title":"J Inherit Metab Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1399-0004.2008.01015.x","article-title":"The skeletal manifestations of the congenital disorders of glycosylation","volume":"73","author":"Coman","year":"2008","journal-title":"Clin Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): quo vadis?","volume":"61","author":"P\u00e9anne","year":"2018","journal-title":"Eur J Med Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1212\/WNL.0b013e3182a08f53","article-title":"Intellectual disability and bleeding diathesis due to deficient CMP\u2013sialic acid transport","volume":"81","author":"Mohamed","year":"2013","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/ajmg.a.38412","article-title":"Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1","volume":"173","author":"Ng","year":"2017","journal-title":"Am J Med Genet A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ajhg.2011.08.008","article-title":"ST3GAL3 mutations impair the development of higher cognitive functions","volume":"89","author":"Hu","year":"2011","journal-title":"Am J Hum Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1111\/epi.12050","article-title":"West syndrome caused by ST3Gal-III deficiency","volume":"54","author":"Edvardson","year":"2013","journal-title":"Epilepsia."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ng1460","article-title":"Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase","volume":"36","author":"Simpson","year":"2004","journal-title":"Nat Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/13816810600862626","article-title":"Etiology of vision loss in ganglioside GM3 synthase deficiency","volume":"27","author":"Farukhi","year":"2006","journal-title":"Ophthalmic Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ejhg.2012.202","article-title":"Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency","volume":"21","author":"Fragaki","year":"2013","journal-title":"Eur J Hum Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/ajmg.a.35826","article-title":"Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency","author":"Wang","year":"2013","journal-title":"Am J Med Genet A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/hmg\/ddt434","article-title":"A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation","volume":"23","author":"Boccuto","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/ajmg.a.37773","article-title":"GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype","volume":"170","author":"Lee","year":"2016","journal-title":"Am J Med Genet A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/ajmg.a.36096","article-title":"Brain magnetic resonance imaging findings in Smith-Lemli-Opitz syndrome","author":"Lee","year":"2013","journal-title":"Am J Med Genet A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3174\/ajnr.A5939","article-title":"Cavum septum pellucidum in the general pediatric population and its relation to surrounding brain structure volumes, cognitive function, and emotional or behavioral problems","volume":"40","author":"Dremmen","year":"2019","journal-title":"AJNR Am J Neuroradiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/jpn.JPN_33_19","article-title":"Peter plus syndrome: a neurosurgeon's perspective","volume":"14","author":"Khatri","year":"2019","journal-title":"J Pediatr Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J Clin Invest."},{"key":"B29","article-title":"Fetal and neonatal cholesterol metabolism","volume-title":"Endotext","author":"Woollett","year":"2000"},{"key":"B30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.118.036484","article-title":"N-glycosylation defects in humans lower low-density lipoprotein cholesterol through increased low-density lipoprotein receptor expression","volume":"140","author":"van den Boogert","year":"2019","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S437","DOI":"10.1007\/s10545-008-1004-9","article-title":"Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx","volume":"31","author":"Calvo","year":"2008","journal-title":"J Inherit Metab Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ajhg.2015.12.010","article-title":"CCDC115 deficiency causes a disorder of Golgi homeostasis with abnormal protein glycosylation","volume":"98","author":"Jansen","year":"2016","journal-title":"Am J Hum Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ajhg.2015.12.011","article-title":"TMEM199 deficiency is a disorder of Golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation","volume":"98","author":"Jansen","year":"2016","journal-title":"Am J Hum Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood-2018-04-847798","article-title":"Mutation in GNE is associated with severe congenital thrombocytopenia","volume":"132","author":"Futterer","year":"2018","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3324\/haematol.2019.225987","article-title":"Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver","volume":"106","author":"Ma","year":"2020","journal-title":"Haematologica."},{"key":"B36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-017-0476-1","article-title":"Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial","volume":"10","author":"Li","year":"2017","journal-title":"J Hematol Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-015-0289-7","article-title":"ALG8-CDG: novel patients and review of the literature","volume":"10","author":"H\u00f6ck","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/ajmg.a.31791","article-title":"Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality","author":"Kranz","year":"2007","journal-title":"Am J Med Genet A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jimd.12162","article-title":"Nonimmune hydrops fetalis and congenital disorders of glycosylation: a systematic literature review","volume":"43","author":"Makhamreh","year":"2020","journal-title":"J Inherit Metab Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood-2018-04-845545","article-title":"GNE variants causing autosomal recessive macrothrombocytopenia without associated muscle wasting","volume":"132","author":"Revel-Vilk","year":"2018","journal-title":"Blood."},{"key":"B41","first-page":"13","article-title":"Role of biochemical markers of bone remodeling in clinical practice","author":"Camozzi","year":"2007","journal-title":"J Endocrinol Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10719-013-9472-z","article-title":"Effects of cell surface \u03b12-3 sialic acid on osteogenesis","volume":"30","author":"Xu","year":"2013","journal-title":"Glycoconj J."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.668640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T02:36:45Z","timestamp":1623033405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.668640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":42,"alternative-id":["10.3389\/fneur.2021.668640"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.668640","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"article-number":"668640"}}